Issue 3/2011
Content (39 Articles)
Interventions for sexual problems following treatment for breast cancer: a systematic review
Sally Taylor, Clare Harley, Lucy Ziegler, Julia Brown, Galina Velikova
Impact of mammographic screening on the detection of good and poor prognosis breast cancers
Laura J. Esserman, Yiwey Shieh, Emiel J. T. Rutgers, Michael Knauer, Valesca P. Retèl, Stella Mook, Annuska M. Glas, Dan H. Moore, Sabine Linn, Flora E. van Leeuwen, Laura J. van ’t Veer
MicroRNA profiles of healthy basal and luminal mammary epithelial cells are distinct and reflected in different breast cancer subtypes
Clemens L. Bockmeyer, Matthias Christgen, Mirco Müller, Sebastian Fischer, Philipp Ahrens, Florian Länger, Hans Kreipe, Ulrich Lehmann
β-Adrenergic receptors (β-AR) regulate VEGF and IL-6 production by divergent pathways in high β-AR-expressing breast cancer cell lines
Kelley S. Madden, Mercedes J. Szpunar, Edward B. Brown
Membrane localization of insulin receptor substrate-2 (IRS-2) is associated with decreased overall survival in breast cancer
Jennifer L. Clark, Karen Dresser, Chung-Cheng Hsieh, Michael Sabel, Celina G. Kleer, Ashraf Khan, Leslie M. Shaw
Elimination of the chemotherapy resistant subpopulation of 4T1 mouse breast cancer by haploidentical NK cells cures the vast majority of mice
Peter W. H. Frings, Catharina H. M. J. Van Elssen, Lotte Wieten, Catarina Matos, Pierre S. J. G. Hupperets, Harry C. Schouten, Gerard M. J. Bos, Michel van Gelder
Agonists and antagonists of GnRH-I and -II reduce metastasis formation by triple-negative human breast cancer cells in vivo
Antje Schubert, Thomas Hawighorst, Günter Emons, Carsten Gründker
Differential expression of arrestins is a predictor of breast cancer progression and survival
Allison M. Michal, Amy R. Peck, Thai H. Tran, Chengbao Liu, David L. Rimm, Hallgeir Rui, Jeffrey L. Benovic
The prognostic role of circulating tumor cells (CTCs) detected by RT-PCR in breast cancer: a meta-analysis of published literature
Shu Zhao, Yupeng Liu, Qingyuan Zhang, Hongbin Li, Minghui Zhang, Wenjie Ma, Wenhui Zhao, Jingxuan Wang, Maopeng Yang
Erratum to: The prognostic role of circulating tumor cells (CTCs) detected by RT-PCR in breast cancer: a meta-analysis of published literature
Shu Zhao, Yupeng Liu, Qingyuan Zhang, Hongbin Li, Minghui Zhang, Wenjie Ma, Wenhui Zhao, Jingxuan Wang, Maopeng Yang
Predictive value of BI-RADS classification for breast imaging in women under age 50
Gannon Kennedy, Matthew Markert, Joseph Richard Alexander, Eli Avisar
Dose-dense doxorubicin and cyclophosphamide followed by dose-dense albumin-bound paclitaxel plus bevacizumab is safe as adjuvant therapy in patients with early stage breast cancer
John Pippen, Devchand Paul, Svetislava Vukelja, Alicia Clawson, Jose Iglesias
Molecular detection of breast cancer metastasis in sentinel lymph nodes by reverse transcriptase polymerase chain reaction (RT-PCR): identifying, evaluating and establishing multi-marker panels
Christian W. Wallwiener, Markus Wallwiener, Ralf R. Kurth, Carmen Röhm, Hans Neubauer, Malgorzata J. Banys, Annette Staebler, Birgitt Schönfisch, Stefan C. Meuer, Thomas Giese, Tanja N. Fehm
Baseline diastolic dysfunction as a predictive factor of trastuzumab-mediated cardiotoxicity after adjuvant anthracycline therapy in breast cancer
Alexandre Cochet, Gaetan Quilichini, Inna Dygai-Cochet, Claude Touzery, Michel Toubeau, Alina Berriolo-Riedinger, Bruno Coudert, Yves Cottin, Pierre Fumoleau, François Brunotte
Survival-adjusted health-related quality of life (HRQL) among patients with metastatic breast cancer receiving paclitaxel plus bevacizumab versus paclitaxel alone: results from Eastern Cooperative Oncology Group Study 2100 (E2100)
David Cella, Molin Wang, Lynne Wagner, Kathy Miller
Effects of zoledronic acid on bone mineral density during aromatase inhibitor treatment of Korean postmenopausal breast cancer patients
Seung Ah Lee, Seung Hyun Hwang, Sung Gwe Ahn, Hak Min Lee, Joon Jeong, Hy-De Lee
Invasive lobular carcinoma: response to neoadjuvant letrozole therapy
J. Michael Dixon, Lorna Renshaw, Jonathan Dixon, Jeremy Thomas
Soy intake in association with menopausal symptoms during the first 6 and 36 months after breast cancer diagnosis
Tsogzolmaa Dorjgochoo, Kai Gu, Ying Zheng, Asha Kallianpur, Zhi Chen, Wei Zheng, Wei Lu, Xiao Ou Shu
Erratum to: Soy intake in association with menopausal symptoms during the first 6 and 36 months after breast cancer diagnosis
Tsogzolmaa Dorjgochoo, Kai Gu, Ying Zheng, Asha Kallianpur, Zhi Chen, Wei Zheng, Wei Lu, Xiao Ou Shu
The impact of obesity on receipt of adjuvant chemotherapy for breast cancer in the National Comprehensive Cancer Network (NCCN) centers
A. M. Brewster, C. Etzel, R. Zhou, Y. Wong, S. Edge, D. W. Blayney, J. Wilson, C. Hudis, R. Ottesen, M. E. Hughes, J. C. Weeks, R. L. Theriault
Single nucleotide polymorphisms in the 20q13 amplicon genes in relation to breast cancer risk and clinical outcome
Hong Shi, Melanie Bevier, Robert Johansson, Ewa Grzybowska, Bowang Chen, Jorunn E. Eyfjörd, Ute Hamann, Jonas Manjer, Kerstin Enquist, Roger Henriksson, Joyce Carlson, Andreas Brandt, Jesús Lascorz, Dorota Butkiewicz, Jolanta Pamula-Pilat, Karolina Tecza, Stefan Herms, Per Hoffmann, Kari Hemminki, Per Lenner, Asta Försti
Birth weight and other prenatal factors and risk of breast cancer in Asian-Americans
Anna H. Wu, Roberta McKean-Cowdin, Chiu-Chen Tseng
Variation in breast cancer risk with mutation position, smoking, alcohol, and chest X-ray history, in the French National BRCA1/2 carrier cohort (GENEPSO)
Julie Lecarpentier, Catherine Noguès, Emmanuelle Mouret-Fourme, Dominique Stoppa-Lyonnet, Christine Lasset, Olivier Caron, Jean-Pierre Fricker, Laurence Gladieff, Laurence Faivre, Hagay Sobol, Paul Gesta, Marc Frenay, Elisabeth Luporsi, Isabelle Coupier, Rosette Lidereau, Nadine Andrieu
Common genetic polymorphisms of microRNA biogenesis pathway genes and risk of breast cancer: a case–control study in Korea
Hyuna Sung, Kyoung-Mu Lee, Ji-Yeob Choi, Sohee Han, Ji-Young Lee, Lian Li, Sue K. Park, Keun-Young Yoo, Dong-Young Noh, Sei-Hyun Ahn, Daehee Kang
The effect of delays in treatment for breast cancer metastasis on survival
Su Yon Jung, Susan M. Sereika, Faina Linkov, Adam Brufsky, Joel L. Weissfeld, Margaret Rosenzweig
Childhood factors associated with mammographic density in adult women
Virginia Lope, Beatriz Pérez-Gómez, María Pilar Moreno, Carmen Vidal, Dolores Salas-Trejo, Nieves Ascunce, Isabel González Román, Carmen Sánchez-Contador, María Carmen Santamariña, Jose Antonio Vázquez Carrete, Francisca Collado-García, Carmen Pedraz-Pingarrón, María Ederra, Francisco Ruiz-Perales, Mercé Peris, Soledad Abad, Anna Cabanes, Marina Pollán
Reproductive factors and histologic subtype in relation to mortality after a breast cancer diagnosis
S. Warren Andersen, P. A. Newcomb, J. M. Hampton, L. Titus-Ernstoff, K. M. Egan, A. Trentham-Dietz
Risk factors for lymphedema in breast cancer survivors, the Iowa Women’s Health Study
Rehana L. Ahmed, Kathryn H. Schmitz, Anna E. Prizment, Aaron R. Folsom
Genetic predictors of taxane-induced neurotoxicity in a SWOG phase III intergroup adjuvant breast cancer treatment trial (S0221)
Lara E. Sucheston, Hua Zhao, Song Yao, Gary Zirpoli, Song Liu, William E. Barlow, Halle C. F. Moore, G. Thomas Budd, Dawn L. Hershman, Warren Davis, Gregory L. Ciupak, James A. Stewart, Claudine Isaacs, Timothy J. Hobday, Muhammad Salim, Gabriel N. Hortobagyi, Julie R. Gralow, Robert B. Livingston, Kathy S. Albain, Daniel F. Hayes, Christine B. Ambrosone
Further evidence for the contribution of the RAD51C gene in hereditary breast and ovarian cancer susceptibility
Mikko Vuorela, Katri Pylkäs, Jaana M. Hartikainen, Karin Sundfeldt, Annika Lindblom, Anna von Wachenfeldt Wäppling, Maria Haanpää, Ulla Puistola, Annika Rosengren, Maarit Anttila, Veli-Matti Kosma, Arto Mannermaa, Robert Winqvist
Combined effects of MDM2 SNP309 and TP53 R72P polymorphisms, and soy isoflavones on breast cancer risk among Chinese women in Singapore
Woon-Puay Koh, David Van Den Berg, Aizhen Jin, Renwei Wang, Jian-Min Yuan, Mimi C. Yu
Mutation analysis of the SLX4/FANCP gene in hereditary breast cancer
Rosa Landwehr, Natalia V. Bogdanova, Natalia Antonenkova, Andreas Meyer, Michael Bremer, Tjoung-Won Park-Simon, Peter Hillemanns, Johann H. Karstens, Detlev Schindler, Thilo Dörk
Serum CD44 levels and overall survival in patients with HER2-positive breast cancer
Jong-Min Baek, Quanri Jin, Joe Ensor, Delphine R. Boulbes, Francisco J. Esteva
Coexistence of breast cancer and tuberculosis in axillary lymph nodes: a case report and literature review
Sami Akbulut, Nilgun Sogutcu, Yusuf Yagmur
FAN1 variants identified in multiple-case early-onset breast cancer families via exome sequencing: no evidence for association with risk for breast cancer
Daniel J. Park, Fabrice A. Odefrey, Fleur Hammet, Graham G. Giles, Laura Baglietto, ABCFS, MCCS, John L. Hopper, Daniel F. Schmidt, Enes Makalic, Olga M. Sinilnikova, David E. Goldgar, Melissa C. Southey
BRCA1 R71K missense mutation contributes to cancer predisposition by increasing alternative transcript levels
Liying Zhang, Lishi Chen, Ruben Bacares, Jeanine M. Ruggeri, Joshua Somar, Yelena Kemel, Zsofia K. Stadler, Kenneth Offit
Prospective study of breast cancer risk for mutation negative women from BRCA1 or BRCA2 mutation positive families
S. L. Harvey, R. L. Milne, S. A. McLachlan, M. L. Friedlander, K. E. Birch, P. Weideman, D. Goldgar, J. L. Hopper, K. A. Phillips
Vascular proliferation is increased in basal-like breast cancer
Hawa Nalwoga, Jarle B. Arnes, Ingunn M. Stefansson, Henry Wabinga, William D. Foulkes, Lars A. Akslen
Need for clarification of data in the recent meta-analysis about TGFBR1*6A/9A polymorphism and breast cancer risk
Ying Zhang